Cancer Care Makes More Progress
WebMD News Archive
Jan. 18, 2002 -- Are you doing your part in the fight against
cancer? The disease accounts for about one in four deaths in the U.S., but we
continue to see improvement year by year, according to a new study published in
the January/February issue of CA: A Cancer Journal for Clinicians.
Cancer is the No. 2 killer in the U.S., behind heart disease.
And most of those deaths are due to four cancers: lung, colorectal, breast, and
Over half a million people are expected to die this year from
cancer, but in the last decade, both the number of cancers and subsequent
deaths from the disease continued to decline.
"This progressive reduction in cancer [frequency] and
mortality, now almost a decade in duration, is a triumph by any standard and a
product of cancer prevention, early diagnosis, screening, and improved cancer
treatment programs widely utilized throughout the country," writes Robert
C. Young, MD, president of the American Cancer Society, in an editorial
accompanying the study. He also is the president of Fox Chase Cancer Center in
African-Americans have proportionally more cancers than other
racial groups in the U.S. And they are less likely to survive when diagnosed
with cancer. However, there is good news to report here as well.
African-American men had the biggest decline in both cancer frequency and
deaths among all ethnic groups.
Among women, the three most-common cancers in 2002 are expected
to be breast, lung, and colorectal. These three cancers should account for
about 55% of all cancers in women. Lung cancer still is expected to be the
biggest cancer killer among women -- as it has been since 1987. Lung cancer is
estimated to account for 25% of deaths, compared to 15% of deaths for breast
For men, prostate, lung, and colorectal cancers will account
for 55% of all new cancers. And though prostate cancer is the No. 1 cancer in
men, it is expected to account for only 11% of deaths. More than 80% of
prostate cancers are expected to be diagnosed early, with nearly 100% of men
surviving at least five years -- considered a cure among cancer experts.